SEARCH

SEARCH BY CITATION

References

  • 1
    Cohen AD, Boyer JD, Weiner DB. Modulating the immune response to genetic immunization. FASEB J 1998;12:161126.
  • 2
    Kowalczyk DW, Ertl HC. Immune responses to DNA vaccines. Cell Mol Life Sci 1999;00:75170.
  • 3
    Ulmer JB, Donnelly JJ, Parker SE et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993;259:17459.
  • 4
    Robinson HL, Boyle CA, Feltquate DM, Morin MJ, Santoro JC, Webster RG. DNA immunization for influenza virus. studies using hemagglutinin- and nucleoprotein-expressing DNAs. J Infect Dis 1997;176 (Suppl. 1):S505.
  • 5
    Deck RR, DeWitt CM, Donnelly JJ, Liu MA, Ulmer JB. Characterization of humoral immune responses induced by an influenza hemagglutinin DNA vaccine. Vaccine 1997;15:718.
  • 6
    Chen Z, Sahashi Y, Matsuo K et al. Comparison of the ability of viral protein-expressing plasmid DNAs to protect against influenza. Vaccine 1998;16:15449.
  • 7
    Operschall E, Pavlovic J, Nawrath M, Molling K. Mechanism of protection against influenza A virus by DNA vaccine encoding the hemagglutinin gene. Intervirology 2000;43:32230.
  • 8
    Okuda K, Ihata A, Watabe S et al. Protective immunity against influenza A virus induced by immunization with DNA plasmid containing influenza M gene. Vaccine 2001;19:368191.
  • 9
    Johnson PA, Conway MA, Daly J, Nicolson C, Robertson J, Mills KH. Plasmid DNA encoding influenza virus haemagglutinin induces Th1 cells and protection against respiratory infection despite its limited ability to generate antibody responses. J General Virol 2000;81 Part 7:17374.
  • 10
    Ulmer JB, Fu TM, Deck RR et al. Protective CD4+ and CD8+ T cells against influenza virus induced by vaccination with nucleoprotein DNA. J Virol 1998;72:564853.
  • 11
    Epstein SL, Stack A, Misplon JA et al. Vaccination with DNA encoding internal proteins of influenza virus does not require CD8 (+) cytotoxic T lymphocytes: either CD4 (+) or CD8 (+) T cells can promote survival and recovery after challenge. Int Immunol 2000;12:91101.
  • 12
    Hunt SV. Preparation of lymphocytes and accessory cells. In: KlausGGB, ed.x Lymphocytes a Practical Approach. Oxford: IRL Press 1987, 134.
  • 13
    Holt PG, Degebrodt A, Venaille T et al. Preparation of interstitial lung cells by enzymatic digestion of tissue slices: preliminary characterization by morphology and performance in functional assays. Immunology 1985;54:13947.
  • 14
    Holt PG, Robinson BW, Reid M et al. Extraction of immune and inflammatory cells from human lung parenchyma: evaluation of an enzymatic digestion procedure. Clin Exp Immunol 1986;66:188200.
  • 15
    Asanuma H, Thompson AH, Iwasaki T et al. Isolation and characterization of mouse nasal-associated lymphoid tissue. J Immunol Meth 1997;202:12331.
  • 16
    Cox RJ, Brokstad KA, Zuckerman MA, Wood JM, Haaheim LR, Oxford JS. An early humoral immune response in peripheral blood following parenteral inactivated influenza vaccination. Vaccine 1994;12:9939.
  • 17
    Reed LJ, Muench HA. A simple method of estimating fifty percent end points. Am J Hyg 1938;27:4937.
  • 18
    Hawkes RA. General principles underlying laboratory diagnosis of viral infections. In: LennetteEH, SchmidtNJ, eds. Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections. Washington DC: American Public Health Association 1979, 345.
  • 19
    Tamura S, Iwasaki T, Thompson AH et al. Antibody-forming cells in the nasal-associated lymphoid tissue during primary influenza virus infection. J General Virol 1998;79:2919.
  • 20
    Pertmer TM, Roberts TR, Haynes JR. Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery. J Virol 1996;70:611925.
  • 21
    Feltquate DM, Heaney S, Webster RG, Robinson HL. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J Immunol 1997;158:227884.
  • 22
    Roman M, Martin-Orozco E, Goodman JS et al. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat Med 1997;3:84954.
  • 23
    Lee SW, Sung YC. Immuno-stimulatory effects of bacterial-derived plasmids depend on the nature of the antigen in intramuscular DNA inoculations. Immunology 1998;94:2859.
  • 24
    Chu RS, Targoni OS, Krieg AM, Lehmann PV, Harding CV. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J Exp Med 1997;186:162331.
  • 25
    Moran TM, Park H, Fernandez-Sesma A, Schulman JL. Th2 responses to inactivated influenza virus can be converted to Th1 responses and facilitate recovery from heterosubtypic virus infection. J Infect Dis 1999;180:57985.
  • 26
    Larsen DL, Dybdahl-Sissoko N, McGregor MW et al. Coadministration of DNA encoding interleukin-6 and hemagglutinin confers protection from influenza virus challenge in mice. J Virol 1998;72:17048.
  • 27
    Operschall E, Schuh T, Heinzerling L, Pavlovic J, Moelling K. Enhanced protection against viral infection by co-administration of plasmid DNA coding for viral antigen and cytokines in mice. J Clin Virol 1999;13:1727.
  • 28
    Iwasaki A, Dela Cruz CS, Young AR, Barber BH. Epitope-specific cytotoxic T lymphocyte induction by minigene DNA immunization. Vaccine 1999;17:20818.DOI: 10.1016/S0264-410X(98)00411-3
  • 29
    Pertmer TM, Oran AE, Madorin CA, Robinson HL. Th1 genetic adjuvants modulate immune responses in neonates. Vaccine 2001;19:176471.DOI: 10.1016/S0264-410X(00)00388-1
  • 30
    Larsen DL, Karasin A, Olsen CW. Immunization of pigs against influenza virus infection by DNA vaccine priming followed by killed-virus vaccine boosting. Vaccine 2001;19:284253.DOI: 10.1016/S0264-410X(01)00014-7
  • 31
    Justewicz DM, Webster RG. Long-term maintenance of B cell immunity to influenza virus hemagglutinin in mice following DNA-based immunization. Virology 1996;224:107.DOI: 10.1006/viro.1996.0501
  • 32
    Justewicz DM, Morin MJ, Robinson HL, Webster RG. Antibody-forming cell response to virus challenge in mice immunized with DNA encoding the influenza virus hemagglutinin. J Virol 1995;69:77127.
  • 33
    Liew FY, Russell SM, Appleyard G, Brand CM, Beale J. Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity. Eur J Immunol 1984;14:3506.
  • 34
    Renegar KB, Small PA Jr. Passive transfer of local immunity to influenza virus infection by IgA antibody. J Immunol 1991;146:19728.
  • 35
    Kuper CF, Koornstra PJ, Hameleers DMH et al. The role of nasopharnygeal lymphoid tissue. Immunol Today 1992;13:21924.